News

Tell us: Do you agree with the FDA’s plan to limit access to COVID vaccines?
The FDA's shift in strategy could make it much harder for people who are younger than 65 and don’t have “risk factors for ...
FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
MIT Technology Review9dOpinion
The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.
At the moment, a lot of people in the US opt to get a covid vaccination around the time they get their annual flu jab. Each ...
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
The Associated Press on MSN12d
New Trump vaccine policy limits access to COVID shots
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The ...
Healthline3d
CDC, FDA Limit Access to COVID Shots for Healthy Adults, Kids, and Pregnant People
The CDC will no longer recommend the COVID-19 vaccine for pregnant women and healthy children. Updated COVID-19 shots will ...
GBH11d
A stricter FDA policy for COVID vaccines could limit future access
Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...
The Cardiology Advisor4d
FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access
The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.
Clinical Advisor4d
FDA’s New Approach to Evaluating COVID-19 Vaccines Will Limit Access, Officials Say
The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have ...